Monopar Therapeutics (MNPR) Operating income 2016–2025
Monopar Therapeutics (MNPR) annual operating income history from SEC filings — each fiscal year as reported.
-$16.7MFY2025 · since FY2016: -$1.2M → -$16.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.7M | -3.4% |
| FY2024 | -$16.2M | -83.0% |
| FY2023 | -$8.8M | +16.2% |
| FY2022 | -$10.5M | -15.4% |
| FY2021 | -$9.1M | -40.2% |
| FY2020 | -$6.5M | -50.5% |
| FY2019 | -$4.3M | -29.8% |
| FY2018 | -$3.3M | +79.9% |
| FY2017 | -$16.6M | -1291.9% |
| FY2016 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice